# DESCRIPTION

## TECHNICAL FIELD

- relate to viral infection control

## BACKGROUND

- introduce CHO cells
- discuss limitations of CHO cells

## SUMMARY OF THE INVENTION

- inhibit viral infection method
- genetically modified cell culture
- biopharmaceutical production method

## DETAILED DESCRIPTION

- incorporate references and define technical terms

### Definitions

- define "a", "an", "the" and "said"
- define "comprising", "including" and "having"
- define "and/or"
- define "consisting" and "consisting essentially of"
- define ranges and numerical values
- define "about"
- define "patient" or "subject"
- define "pharmaceutical composition"
- define "combination"
- define "co-administration" and "combined administration"
- define "pharmaceutical combination"
- define "fixed combination" and "non-fixed combination"
- define "pharmaceutically acceptable"
- define "pharmaceutically acceptable carrier"
- define "therapeutically effective"
- define "treat", "treatment", and "treating"
- define "prevent", "preventing", and "prevention"
- define "prophylactically effective amount"
- define "antibody" and "antibody fragments"

### Example 1

- introduce CHO-K1 cells and RNA viruses
- describe virus infection and innate immune modulator treatment
- outline Western blot procedures
- detail RNA extraction, purification, and quality control procedure
- describe cDNA library construction and next-generation sequencing (RNA-Seq)
- outline RNA-Seq quantification and differential gene expression analysis
- describe genetic engineering of CHO-S cell lines
- detail single cell sorting, clone genotyping, and expansion
- describe plasmid construction for Gfi1 and Trim24 gene KO
- outline oligos used in cloning reaction
- summarize cell harvesting and cytopathic effect visualization

### Results and Discussion

- evaluate CHO cell response to RNA viruses
- describe cytopathic effects and gene expression changes
- analyze type I IFN response in CHO cells
- identify limitations of type I IFN response
- conduct RNA-Seq and pathway analysis
- analyze modulation of immune-related gene sets and pathways
- explore differences in type I IFN response between viruses
- induce type I IFN response with poly I:C
- analyze transcriptome of poly I:C-treated CHO cells
- characterize type I IFN response induced by poly I:C
- examine protection of CHO cells from RNA virus infections
- analyze transcriptomic differences between viruses
- identify genes differently modulated by poly I:C treatment
- analyze regulatory network governing viral resistance
- identify upstream regulators of STAT1
- delete Trim24 and Gfi1 to induce CHO cell innate immunity
- evaluate impact of gene editing on virus susceptibility

### Example 2

- perform GSEA
- analyze leading edge
- predict upstream regulators
- test type I IFN protection
- examine poly I:C pre-treatment effect
- identify STAT1 upstream regulators

